Cochrane Evidence Synthesis and Methods ►

Catheter ablation versus escalation of antiarrhythmic medications for management of ventricular tachycardia in patients with ischaemic heart disease

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess and compare the effects of catheter ablation for ventricular tachycardia (VT) with escalation of antiarrhythmic drugs (AADs) in patients with ischaemic heart disease (IHD).

This is a protocol.

Published:

14 December 2021

Authors:

Kakarla J, Benson C, Abbas M, Begg G, Twomey D, Thornley A, Bates M, Ahmad M, Arif H, Banerjee A, Manmathan GP, Lambiase PD, James S

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Kakarla J, Benson C, Abbas M, Begg G, Twomey D, Thornley A, Bates M, Ahmad M, Arif H, Banerjee A, Manmathan GP, Lambiase PD, James S. Catheter ablation versus escalation of antiarrhythmic medications for management of ventricular tachycardia in patients with ischaemic heart disease (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 12. Art. No.: CD014733. DOI: 10.1002/14651858.CD014733.